See how to achieve faster drug development, with less effort, and less manual work. The Pinnacle 21 software suite augments your capabilities – helping you quickly build validated studies, get cleaner vendor data (minus the delays), and speed time-to-analysis.
Powered by technology, you’ll be able to extract data insights earlier, and increase the speed and quality of submission deliverables.
Standardize and reuse content, saving time & effort on study setup.
See how CRFs look and work for your chosen EDC – as you’re designing forms in Pinnacle 21.
Increase quality with real-time validation and issue resolution, all in one central platform.
Reduce data delivery timelines and get compliant data from vendors.
“Working in a platform like Pinnacle 21 has helped us meet the needs of our clients faster. And they can be confident that the data we provide is in a standardized format they can use to drive decisions right away.”
Liming Fang
Deputy General Manager, Longcharm Biomedical Technology
Schedule a demo or consultation to see how Pinnacle 21 can accelerate your path from study design to submission.
Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.
From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
© 2025 Certara. All Rights Reserved. | Privacy policy